TRAIL与kallistatin联合表达载体的构建及抗肿瘤活性分析

为研究肿瘤坏死因子相关凋亡诱导配体(TRAIL)与组织激肽释放酶结合蛋白(kallistatin)联合用药的抗肿瘤作用,构建TRAIL与kallistatin双表达的重组质粒pAM-CAG-Kal-IRES-TRAIL,将重组质粒转染A549,LO-2,NCI-H446和Hela细胞,考察其抗肿瘤活性.实验结果表明:构建的双表达载体能同时表达TRAIL与kallistatin,且均能分泌至培养基中;TRAIL与kallistatin联合表达对肿瘤细胞活力的抑制作用明显增强,诱导肿瘤凋亡的作用也明显增强,说明联合表达TRAIL与kallistatin能够增强抗肿瘤活性.     

凋亡抑制蛋白与肿瘤关系的研究

凋亡抑制蛋白(inhibitor of apoptosis proteins,IAPs)可以作为癌症诊断和治疗的靶点,在肿瘤研究方面备受关注,就凋亡抑制蛋白的结构、功能、在肿瘤中的表达与肿瘤的关系等研究进展作一综述,为凋亡抑制蛋白的研究提供信息和思路.     

肿瘤患者的心理分析及护理

分析了肿瘤患者心理变化4个阶段的不同表现,并针对此提出相应心理护理的方式。指出加强肿瘤患者的心理分析及护理是保证顺利治愈的重要环节。     

鸭血烯酸对艾氏癌生长的抑制作用

鸭血烯酸是由鸭血清中提取的不饱和脂肪酸．在体外实验中具有使艾氏腹水癌细胞膨胀失活的作用．用于治疗艾氏癌患鼠,可抑制其腹水癌和实体瘤的生长．与环磷酰胺（CPA）或氟脲嘧啶（SFU）相比,鸭血烯酸的毒性较低,疗效较高,约20％～40％被治愈的患鼠,可长期存活．     

针刺对胸内肿瘤化学疗法中自由基等指标的影响

恶性肿瘤的化学疗法会产生自由基升高和白细胞数目降低等副作用,临床表现恶心、呕吐、厌食、疲乏等症状。 本文应用针刺“足三里”、“阴陵泉”、“内关”等穴位配合化学疗法,结果血中脂质过氧化物(LPO)降低,白细胞增多、消化道症状和疲乏感降低,这说明针刺疗法可作为化学疗法的重要支持手段。 针刺降低自由基的原理估计是激发了体内降解酶的作用。     

颈部肿块细针吸取细胞学诊断

2000—2002年进行颈部肿块细针吸取细胞学检查共600例，有病理组织学证实138例，其中恶性病变66例。淋巴结、甲状腺各占60．10％、23．50％。细胞学阳性158例，占26．33％，可疑恶性32例，占5．33％。和术后病理组织学诊断对照。恶性病变符合率80．30％，良性病变符合率为93．06％，总符合率为86．96％。敏感率(阳性 可疑)淋巴结、甲状腺分别为96．29％和90．00％。本文对假阳性、假阴性病例进行了分析。     

Inhibitory effect of the adenovirus type 5 E1A protein expressed in the yeast system

The human adenovirus type 5 E1A, a tumor- suppressor gene[1], codes for two major related proteins of 243 amino acids (12S) and 289 amino acids (13S) by al-ternative splicing in two exons[2]. Studies have been shown that E1A can regulate expression of many genes and cell cycle[3]. Both in vitro and in vivo experiments indicated that E1A could induce tumor cells differentia-tion, convert tumor cells into an epithelial phenotype, in-hibit tumor cell growth and metastasis and strongly en-ha…     

Inhibitory effect of the adenovirus type 5 E1A protein expressed in the yeast system of the human tumor cell growth

Adenovirus 5 type E1A as a tumor suppressor gene can inhibit tumor growth and enhance the censitivity of chemotherapy and radiotherapy.E1A have the ability to integrate into the host genome,resulting in long-time expres-sion that induces Rb gene inactivation and animal cells im-mortalization.This prompted us to select the E1A protein for treatment of cancer in order to overcome the limitations of E1A gene therapy.Thus,we firstly comstructed E1A eu-caryotic expression vector (pPIC9/E1A),transformated the pichia pastoris yeast cells(GS115) and screened the high-expressing recombinant strains.The positive yeast strains were cultured in the shake flask,and induced for 3d.The crude E1A protein was purified using two steps of col-umu chromatography on HiTrap Q and HiTrap SP.The pu-rified E1A protein was identified by SDS-PAGE and Western blot.E1A protein was mostly located at cellular unclear when Cheriot delivered E1A protein into cells.The analysis in vitro indicated that the E1A protein arrested LN686 cell cycle at G2/M phase,and significantly inhibited the growth of LN686 tumor cells.The current studies firstly provided an experimental basis to further develop E1A protein for tumor treatment.     

恶性肿瘤患者与健康人血清Cu、Zn、Ca、Mg、Se含量及Cu／Zn比值的对比分析

用ＩＣＰ－ＡＥＳ法测定了４４例恶性肿瘤患者和３３例健康人血清Ｃｕ、Ｚｎ、Ｃａ、Ｍｇ、Ｓｅ含量．结果显示：恶性肿瘤组血清Ｃａ、Ｓｅ含量低于健康组，血清Ｃｕ含量高于健康组，两组相比较，均有非常显著差异（Ｐ＜０．０１）．提示上述元素可能与恶性肿瘤的发生、发展有一定关系．     

顺铂联合白细胞介素-2治疗恶性胸腔积液32例

目的：探讨胸腔注入顺铂（DDP）联合白细胞介素-2（IL-2）治疗恶性胸腔积液疗效。方法：58例患者均病理确诊为恶性胸腔积液，随机分为二组，治疗组（32例）在胸腔内注入DDP，白细胞介素-2，对照组（26例）在胸腔内注A．DDP，两组均在1周及2周后各重复注药1次，共3次，观察疗效，毒副反应及生活质量。结果：治疗组总有效率为84．4％，对照组57．7％，差异有显著性（P〈0．015）。治疗组Kamofsky评分〉70分者较对照组有显著提高（P〈0．05），两组在毒性反应上无显著性差异（P〉0．05）。结论：顺铂白介素-2胸腔灌注能有效控制恶性胸腔积液，毒副作用少，联合疗效肯定。